"We truly held a groundbreaking technology in an emerging field where only “me-too” and “me-better” products were available in the international market."
In Conversation
Sergio Olivares, managing director at Olivares, explains the TPP’s impact on the Mexican pharmaceutical industry’s dynamism and Olivares’ business proposal as a one-stop shop solution to…
"Switzerland Innovation is to be an additional tool to further develop Switzerland’s innovative ecosystem, and keep our position as the most innovative country in the world."
"The mission for me and all my peers around the world is the same: be the main provider of innovative solutions for the challenges of the…
"We have leading universities, world-class research institutions, a highly-qualified workforce and unrivalled skills in the precision industry derived from a tradition of watchmaking."
From a product development perspective, as regulatory hurdles are constantly increasing, so is the price of the development: the average cost of developing a drug with…
"I am proud to confirm that the Mexican CRO industry now fully complies with the highest international quality standards."
"Since its conception, I have deeply believed that this novel EMT antagonist holds the potential to bring groundbreaking treatments to international patients"
Interview: Luca G. Guidotti – Deputy Scientific Director, San Raffaele Scientific Institute (SRSI), Italy

"Both in terms of research and clinical care, we do not think in terms of single specialty areas. Instead we cover all biomedical areas."
Interview: Gianvito Martino – Scientific Director & Director of the Division of Neuroscience, San Raffaele Scientific Institute (SRSI), Italy

"Our division of neuroscience publishes more than 250 scientific publications per year."
Interview: Angelo Corti – Director, Division of Experimental Oncology, San Raffaele Scientific Institute (SRSI), Italy

"Cancer is not one disease; rather it is a collection of many different diseases that require specific diagnostic and therapeutic tools, specialized researchers and physicians."
Interview: Paola Pozzi – Head, Office of Biotechnology Transfer, San Raffaele Scientific Institute (SRSI), Italy

"We need to understand medical and market needs and speak different languages (science, law and business) to interact effectively both with the scientific community and with…